Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
126.50
+2.00 (1.61%)
Nov 6, 2026, 1:30 PM CST

TPEX:3218 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,2744,2044,2284,0823,4942,632
Revenue Growth
0.24%-0.57%3.58%16.83%32.76%28.18%
Gross Profit
2,4872,4832,5332,4482,1401,636
Operating Income
1,3351,3801,3981,3121,081768.54
Net Income
1,1451,0431,0651,045850.53595.43
Earnings Per Share
13.4612.2612.5312.3110.027.02
EPS Growth
28.87%-2.15%1.79%22.85%42.76%23.22%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Adjustment and Elimination
-152.47-147.8-208.48-270.87--235.27
Medical Operations Department
3,2773,2593,4413,4722,7512,248
Optical Operation Department
1,1491,093995.97880.79742.82619
Total
4,2744,2044,2284,0823,4942,632

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0292,1031,9171,6411,2801,040
Total Debt
1,5081,0631,054778.26783.65767.53
Net Cash (Debt)
-478.921,040863.2862.65495.99272.47
Net Cash Growth
-20.47%0.07%73.92%82.03%-41.23%
Net Cash Per Share
-5.6312.2310.1610.165.853.21

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7781,6661,6721,5541,268911.77
Capital Expenditures
-470.58-562.66-434.65-472.53-489.7-324.44
Free Cash Flow
1,3071,1041,2371,081778.47587.33
Free Cash Flow Growth
5.03%-10.80%14.46%38.87%32.55%10.41%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.19%59.05%59.91%59.98%61.24%62.18%
Operating Margin
31.24%32.83%33.06%32.14%30.94%29.20%
Pretax Margin
33.15%32.01%31.17%32.30%31.26%29.00%
Profit Margin
26.78%24.80%25.18%25.60%24.34%22.62%
FCF Margin
30.58%26.25%29.27%26.48%22.28%22.32%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
7.7507.7507.5007.0005.6604.492
Dividend Per Share Growth
3.33%3.33%7.14%23.67%26.00%19.05%
Dividend Yield
6.13%5.31%3.75%2.53%2.01%1.77%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.4011.8615.9222.4628.0536.18
Forward PE
9.1310.6615.2419.4124.6727.75
P/FCF Ratio
8.2011.2113.6921.7130.6536.68
PS Ratio
2.512.944.015.756.838.19